Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

NCT Number	NCT07637071
Lead Sponsor	Restore Biologics Holdings, Inc. dba Xtressé
Conditions	Androgenic Alopecia, Hair Loss/Baldness, Hair Thinning
Enrollment	40 participants
Start Date	2026-06-22
Primary Completion	2027-01 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-10